Literature DB >> 28068659

Hearing Loss after Round Window Surgery in Mice Is due to Middle Ear Effusion.

Bovey Z Zhu1, Jasmine Saleh, Kevin T Isgrig, Lisa L Cunningham, Wade W Chien.   

Abstract

BACKGROUND: Delivery of therapeutic agents directly through the round window (RW) offers promise for treating sensorineural hearing loss. However, hearing loss can result from the surgical approach itself, and the reasons for this are poorly understood. We examined the hearing loss following the 3 major steps involved with the RW approach to access the mouse cochlea: bullostomy, RW puncture, and RW injection.
METHODS: Twenty-one adult CBA/J mice underwent bullostomy alone, 10 underwent RW puncture, and 8 underwent RW injection with PBS with 5% glycerol. Auditory brainstem responses (ABR) and otoscopy were performed preoperatively and up to 6 weeks postoperatively. Hair cells were stained, and survival was assessed using immunofluorescence.
RESULTS: One week postoperatively, mice in all groups showed significant threshold shifts. Otoscopy revealed approximately half of all mice had middle ear effusion (MEE), with a higher incidence of effusion in the RW puncture and RW injection groups. Those with MEE had significant ABR threshold shifts, whereas those without MEE had minimal hearing loss. MEE persisted through 6 weeks in a majority of cases, but in those mice with MEE resolution, there was at least partial improvement in hearing. Immunohistochemistry showed minimal loss of hair cells in all animals.
CONCLUSION: MEE is highly correlated with hearing loss in mice undergoing RW surgery. Otoscopy is an important adjunct to consider after ear surgery in mice, as MEE may contribute to postsurgical hearing loss.
© 2017 S. Karger AG, Basel.

Entities:  

Keywords:  Ear surgery; Gene therapy; Hearing loss; Inner ear; Middle ear; Round window membrane

Mesh:

Year:  2017        PMID: 28068659      PMCID: PMC6414062          DOI: 10.1159/000449239

Source DB:  PubMed          Journal:  Audiol Neurootol        ISSN: 1420-3030            Impact factor:   1.854


  7 in total

1.  Canalostomy As a Surgical Approach to Local Drug Delivery into the Inner Ears of Adult and Neonatal Mice.

Authors:  Jing-Ying Guo; Lu He; Teng-Fei Qu; Yu-Ying Liu; Ke Liu; Guo-Peng Wang; Shu-Sheng Gong
Journal:  J Vis Exp       Date:  2018-05-25       Impact factor: 1.355

Review 2.  Antisense Oligonucleotides for the Treatment of Inner Ear Dysfunction.

Authors:  Michelle L Hastings; Timothy A Jones
Journal:  Neurotherapeutics       Date:  2019-04       Impact factor: 7.620

3.  Refining surgical techniques for efficient posterior semicircular canal gene delivery in the adult mammalian inner ear with minimal hearing loss.

Authors:  Jianliang Zhu; Jin Woong Choi; Yasuko Ishibashi; Kevin Isgrig; Mhamed Grati; Jean Bennett; Wade Chien
Journal:  Sci Rep       Date:  2021-09-22       Impact factor: 4.996

4.  Intratympanic Diltiazem-Chitosan Hydrogel as an Otoprotectant Against Cisplatin-Induced Ototoxicity in a Mouse Model.

Authors:  James G Naples; Michael J Ruckenstein; Jarnail Singh; Brandon C Cox; Daqing Li
Journal:  Otol Neurotol       Date:  2020-01       Impact factor: 2.619

5.  A Single Cisterna Magna Injection of AAV Leads to Binaural Transduction in Mice.

Authors:  Fabian Blanc; Alexis-Pierre Bemelmans; Corentin Affortit; Charlène Joséphine; Jean-Luc Puel; Michel Mondain; Jing Wang
Journal:  Front Cell Dev Biol       Date:  2022-01-11

6.  AAV2.7m8 is a powerful viral vector for inner ear gene therapy.

Authors:  Kevin Isgrig; Devin S McDougald; Jianliang Zhu; Hong Jun Wang; Jean Bennett; Wade W Chien
Journal:  Nat Commun       Date:  2019-01-25       Impact factor: 14.919

Review 7.  rAAV-Mediated Cochlear Gene Therapy: Prospects and Challenges for Clinical Application.

Authors:  Fabian Blanc; Michel Mondain; Alexis-Pierre Bemelmans; Corentin Affortit; Jean-Luc Puel; Jing Wang
Journal:  J Clin Med       Date:  2020-02-21       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.